🔴 Alzamend Neuro is trading 8% down in pre-market after sharp after-hours reversal

Alzamend Neuro is trading at $1.50, down 7.96% after a sharp after-hours reversal.

• The stock closed at $1.63 on August 20, 2026.
• The latest company news was positive: AL001 neuroimaging data were accepted for presentation at Neuroscience 2026.
• No negative company-specific announcement was identified; with major indexes currently higher pre-market, the catalyst remains unclear rather than clearly tied to broad market sentiment.